These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 22820603)

  • 21. CD1d-lipid antigen recognition by the γδ TCR.
    Uldrich AP; Le Nours J; Pellicci DG; Gherardin NA; McPherson KG; Lim RT; Patel O; Beddoe T; Gras S; Rossjohn J; Godfrey DI
    Nat Immunol; 2013 Nov; 14(11):1137-45. PubMed ID: 24076636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benzofuran sulfonates and small self-lipid antigens activate type II NKT cells via CD1d.
    Almeida CF; Smith DGM; Cheng TY; Harpur CM; Batleska E; Nguyen-Robertson CV; Nguyen T; Thelemann T; Reddiex SJJ; Li S; Eckle SBG; Van Rhijn I; Rossjohn J; Uldrich AP; Moody DB; Williams SJ; Pellicci DG; Godfrey DI
    Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34417291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
    Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR
    J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity.
    Zajonc DM; Maricic I; Wu D; Halder R; Roy K; Wong CH; Kumar V; Wilson IA
    J Exp Med; 2005 Dec; 202(11):1517-26. PubMed ID: 16314439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked self-glycolipid.
    Arrenberg P; Halder R; Dai Y; Maricic I; Kumar V
    Proc Natl Acad Sci U S A; 2010 Jun; 107(24):10984-9. PubMed ID: 20534460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition.
    Kjer-Nielsen L; Borg NA; Pellicci DG; Beddoe T; Kostenko L; Clements CS; Williamson NA; Smyth MJ; Besra GS; Reid HH; Bharadwaj M; Godfrey DI; Rossjohn J; McCluskey J
    J Exp Med; 2006 Mar; 203(3):661-73. PubMed ID: 16505140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
    Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
    J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal structures of bovine CD1d reveal altered αGalCer presentation and a restricted A' pocket unable to bind long-chain glycolipids.
    Wang J; Guillaume J; Pauwels N; Van Calenbergh S; Van Rhijn I; Zajonc DM
    PLoS One; 2012; 7(10):e47989. PubMed ID: 23110152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A molecular basis for NKT cell recognition of CD1d-self-antigen.
    Mallevaey T; Clarke AJ; Scott-Browne JP; Young MH; Roisman LC; Pellicci DG; Patel O; Vivian JP; Matsuda JL; McCluskey J; Godfrey DI; Marrack P; Rossjohn J; Gapin L
    Immunity; 2011 Mar; 34(3):315-26. PubMed ID: 21376640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide.
    Jahng A; Maricic I; Aguilera C; Cardell S; Halder RC; Kumar V
    J Exp Med; 2004 Apr; 199(7):947-57. PubMed ID: 15051763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD1d-specific NK1.1+ T cells with a transgenic variant TCR.
    Sköld M; Faizunnessa NN; Wang CR; Cardell S
    J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular basis of lipid antigen presentation by CD1d and recognition by natural killer T cells.
    Girardi E; Zajonc DM
    Immunol Rev; 2012 Nov; 250(1):167-79. PubMed ID: 23046129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells.
    Gerth E; Mattner J
    Front Immunol; 2019; 10():1449. PubMed ID: 31293596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recognition of β-linked self glycolipids mediated by natural killer T cell antigen receptors.
    Pellicci DG; Clarke AJ; Patel O; Mallevaey T; Beddoe T; Le Nours J; Uldrich AP; McCluskey J; Besra GS; Porcelli SA; Gapin L; Godfrey DI; Rossjohn J
    Nat Immunol; 2011 Jul; 12(9):827-33. PubMed ID: 21804559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural evaluation of potent NKT cell agonists: implications for design of novel stimulatory ligands.
    Schiefner A; Fujio M; Wu D; Wong CH; Wilson IA
    J Mol Biol; 2009 Nov; 394(1):71-82. PubMed ID: 19732779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Vα14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode.
    Li Y; Girardi E; Wang J; Yu ED; Painter GF; Kronenberg M; Zajonc DM
    J Exp Med; 2010 Oct; 207(11):2383-93. PubMed ID: 20921281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural basis of NKT cell inhibition using the T-cell receptor-blocking anti-CD1d antibody 1B1.
    Ying G; Wang J; Mallevaey T; Van Calenbergh S; Zajonc DM
    J Biol Chem; 2019 Aug; 294(35):12947-12956. PubMed ID: 31296659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TCRα-TCRβ pairing controls recognition of CD1d and directs the development of adipose NKT cells.
    Vieth JA; Das J; Ranaivoson FM; Comoletti D; Denzin LK; Sant'Angelo DB
    Nat Immunol; 2017 Jan; 18(1):36-44. PubMed ID: 27869818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type II NKT Cells: An Elusive Population With Immunoregulatory Properties.
    Singh AK; Tripathi P; Cardell SL
    Front Immunol; 2018; 9():1969. PubMed ID: 30210505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.